000 01613 a2200469 4500
005 20250518034627.0
264 0 _c20190826
008 201908s 0 0 eng d
022 _a2157-846X
024 7 _a10.1038/s41551-018-0203-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLu, Kuangda
245 0 0 _aLow-dose X-ray radiotherapy-radiodynamic therapy via nanoscale metal-organic frameworks enhances checkpoint blockade immunotherapy.
_h[electronic resource]
260 _bNature biomedical engineering
_c08 2018
300 _a600-610 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCell Line, Tumor
650 0 4 _aCombined Modality Therapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy
_xmethods
650 0 4 _aMetal-Organic Frameworks
_xchemistry
650 0 4 _aMice
650 0 4 _aNanomedicine
650 0 4 _aNanostructures
_xchemistry
650 0 4 _aX-Ray Therapy
_xmethods
700 1 _aHe, Chunbai
700 1 _aGuo, Nining
700 1 _aChan, Christina
700 1 _aNi, Kaiyuan
700 1 _aLan, Guangxu
700 1 _aTang, Haidong
700 1 _aPelizzari, Charles
700 1 _aFu, Yang-Xin
700 1 _aSpiotto, Michael T
700 1 _aWeichselbaum, Ralph R
700 1 _aLin, Wenbin
773 0 _tNature biomedical engineering
_gvol. 2
_gno. 8
_gp. 600-610
856 4 0 _uhttps://doi.org/10.1038/s41551-018-0203-4
_zAvailable from publisher's website
999 _c29618591
_d29618591